Apollomics (APLM) Enterprise Value (2020 - 2025)

Apollomics (APLM) posted quarterly Enterprise Value of -$3.3 million for Q4 2025, up 92.83% quarter-over-quarter from -$45.7 million in Q2 2023.

Apollomics (APLM) Enterprise Value (2020 - 2025) Analysis & Trends

Apollomics (APLM) has reported Enterprise Value for 5 consecutive years, with -$3.3 million the latest figure, recorded in Q4 2025.

In Q4 2025, Enterprise Value changed N/A year-over-year to -$3.3 million; the TTM figure through Dec 2025 stood at -$3.3 million (changed N/A YoY), while the FY2025 annual figure was -$3.3 million, changed N/A from the prior year.
Enterprise Value grew to -$3.3 million in Q4 2025 per APLM's latest filing, from -$45.7 million in the prior quarter.
Across five years, Enterprise Value topped out at -$3.3 million in Q4 2025 and bottomed at -$51.7 million in Q4 2022.
Historically, Enterprise Value has averaged -$36.3 million across 4 years, with a median of -$45.7 million in 2023.
Annual changes were most pronounced in 2021 — Enterprise Value jumped 76.86% — and 2022, when it plunged 71.16%.
Apollomics' Enterprise Value stood at -$30.2 million in 2021, then slumped by 71.16% to -$51.7 million in 2022, then grew by 11.68% to -$45.7 million in 2023, then jumped by 92.83% to -$3.3 million in 2025.
Business Quant data shows APLM's Enterprise Value at -$3.3 million in Q4 2025, -$45.7 million in Q2 2023, and -$51.7 million in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Enterprise Value (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-7.85 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	-7.99 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-5.18 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-5.14 Bn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	-5.10 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-3.31 Bn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-1.16 Bn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	2.12 Bn
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-18.39 Bn
10	Apollomics	34.08 Mn	30.81 Mn	-	-3.28 Mn

Download Data